Stomach cancer (credit: canva)
Stomach cancer is a type of cancer that develops in the lining of the stomach. Also, known as Gastric cancer, it affects the elderly more than the adult. According to the American Cancer Society, about 6 of every 10 people diagnosed with stomach cancer each year are 65 or older. Also, the lifetime risk of developing stomach cancer is higher in men (about 1 in 101) than in women (about 1 in 155).
A health expert, speaking to a leading media house, emphasized five common symptoms of stomach cancer that should not be ignored:
1. Unexplained weight loss: Losing weight without trying or experiencing an unexplained drop in appetite, which may signal cancer progression.
2. Pain in the upper part of the abdomen: Persistent or occasional pain in the stomach area, often after eating, can become more severe as the condition progresses.
3. Frequent vomiting after meals: Nausea, sometimes accompanied by vomiting, may occur especially after meals and is linked to cancer blocking or irritating the stomach.
4. Vomiting blood, which may appear coffee-colored: This can indicate bleeding in the stomach, often caused by ulcers or tumors, and requires immediate medical attention.
5. Black, tarry stools: This occurs when blood from the stomach is digested and passed through the intestines, signaling potential internal bleeding
There are also other concerning signs that should not be overlooked such as jaundice, unexplained weight loss, early onset of diabetes, dark stools, and loss of appetite. Health experts strongly advise seeking immediate medical attention if you notice any of these symptoms. If you or a loved one experience these signs, it's crucial to visit a physician for a thorough evaluation to rule out serious underlying health conditions.
Oncologist Dr Pankaj Kumar Pande, Director–Surgical Oncology, Max Super Specialty Hospital, Shalimar Bagh, Delhi explained that this form of cancer spreads through three main pathways: Direct spread, lymphatic spread, and bloodstream.
1. Direct Spread: In its early stages, stomach cancer can invade nearby tissues and grow into the deeper layers of the stomach or spread to surrounding organs such as the oesophagus, liver, pancreas, or intestines.
2. Lymphatic Spread: Cancer cells can travel through the lymphatic system. The most common areas affected are the regional lymph nodes near the stomach, particularly those around the liver and diaphragm.
3. Bloodstream: "Cancer cells can enter the bloodstream and travel to distant parts of the body," which is a common route for stomach cancer to metastasize to distant organs.
He further explained that cancerous cells spread from the original tumour to other parts of the body through a process called Metastasis. The most common sites for the spread are the liver, lymph nodes, peritoneum, lungs, bones, and ovaries.
Credit: iStock
The World Health Organization (WHO) has warned that West Nile virus infections are increasing across parts of Europe, with hotter temperatures, longer summers, and changing weather patterns creating ideal conditions for mosquito-borne disease transmission.
The warning comes as Europe grapples with intense heatwaves and widespread wildfires, which experts say are contributing to the spread of disease-carrying mosquitoes.
Greece has recorded the sharpest recent increase, with 21 confirmed human cases as of July 22, including 14 reported in the previous week alone.
Of these, 20 patients developed neuroinvasive disease, such as encephalitis or meningitis, and 13 remain hospitalized.
Italy has reported the widest geographic spread, with 21 confirmed cases across 17 different areas as of July 15. Locally acquired infections have also been reported in North Macedonia (2 cases), Romania (2), and Spain (2).
The WHO noted that while the risk remains low for most people, it may turn deadly for some.
"West Nile virus is not a new threat, but the conditions driving its spread are changing rapidly," said Dr. Hans Henri P. Kluge, WHO Regional Director for Europe.
“Most infections are mild, but roughly 1 in 150 people who contract the virus will develop a severe infection affecting the central nervous system, which can be life-threatening,” he added.
Kluge added that warmer temperatures and longer summers are giving mosquitoes more time and a wider geographic range to transmit the virus.
West Nile virus is spread primarily through the bite of an infected mosquito. Mosquitoes become infected after feeding on infected birds and can then transmit the virus to humans and other animals.
In Europe, infections typically occur during the mosquito season—from late spring through autumn—with transmission peaking between July and September.
Although rare, the virus has also been transmitted through blood transfusions, organ transplantation, pregnancy, and breastfeeding. There is no evidence of person-to-person transmission through everyday contact.
Currently, there is no licensed vaccine for humans and no specific antiviral treatment. Care focuses on relieving symptoms, while severe cases may require hospital-based supportive treatment.
Around 70–80% of infected people develop no symptoms.
Those who do become ill may experience:
In severe cases, the infection can affect the nervous system, causing:
Anyone who develops symptoms after returning from an area where the virus is circulating should seek medical attention promptly. People with severe symptoms require urgent medical care.
West Nile virus infection can be confirmed through laboratory tests that detect virus-specific antibodies or viral RNA, depending on the stage of illness.
As there is no vaccine or specific treatment, WHO says prevention depends on avoiding mosquito bites and reducing mosquito breeding sites.
WHO recommends:
Credit: AI
Israel’s military is facing an alarming mental health crisis as prolonged geopolitical conflict continues to take a psychological toll on its soldiers.
Recently, two female Israeli soldiers died by suicide within days of each other, bringing the number of active-duty military suicides this year to at least 16, according to Israeli media.
The deaths in the force have reignited concerns over whether the military personnel are receiving necessary trauma and mental health care
The latest cases involved a combat soldier from the Bardelas Battalion and an intelligence officer. Military Police have launched investigations, while the Israel Defense Forces (IDF) has acknowledged the incidents, saying that the affected units are being supported in every way.
According to Israel’s Defence Ministry, cases of post-traumatic stress disorder (PTSD) among soldiers have increased by nearly 40% since 2023.
Of more than 22,000 personnel receiving treatment for war-related injuries, around 60% are being treated primarily for psychological trauma.
“Soldiers are grappling not only with fear for their own lives, but also with moral injury resulting from witnessing or participating in traumatic events,” clinical psychologist Ronen Sidi of Emek Medical Center told Reuters.
Also read: Many US Veterans With Suicidal Thoughts May Not Be Receiving Mental Health Treatment, Study Finds
Unlike PTSD, which is often linked to fear-based traumatic experiences, moral injury refers to when patients feel they have violated deeply held moral or ethical beliefs, or witnessed events that violate those values.
Military psychologists say constant exposure to civilian casualties, loss of troops, and conflicting decisions on the battlefield can leave lasting emotional wounds that last for a long time.
The two recent suicides are not isolated incidents. Earlier this year, Israeli media reported that many soldiers on active duty had taken their own lives after returning from their deployments.
Some reports also said that soldiers who were discharged are struggling with severe PTSD, depression and social isolation after leaving service. Researchers say many continue to battle mental health issues long after their duty ends.
Veterans’ organisations have increasingly called for comprehensive and effective rehabilitation services, saying that untreated trauma may surface months or even years after military service ends.
Also read: US Government Backs Psychedelic Therapies Research For Veterans With PTSD and Depression
The Israeli Defence Ministry says it has expanded mental health services, funding and introduced alternative therapies to improve mental health recovery for soldiers who are struggling.
However, some recent reports have questioned whether those services are reaching troops quickly enough. Critics have pointed to shortages of field psychologists, cancelled mental health support days and unsuccessful recognition of warning signs.
Mental health specialists also say that stigma remains another barrier. Despite growing awareness, many soldiers hesitate to seek help because they believe that doing so could affect their careers or be viewed as a sign of weakness.
For Israel, the growing number of soldier suicides is becoming a stark reminder that the cost of war is measured not only in physical casualties, but also in the invisible wounds that reflect through mental health issues.
Credit: iStock
Uganda has officially ended the Ebola outbreak after completing the mandatory 42-day monitoring period with no new infections, even as neighboring Democratic Republic of the Congo (DRC) continues to battle its worst outbreak of the deadly disease in years.
Ugandan Health Minister Chris Baryomunsi announced the "successful completion of the mandatory 42-day monitoring period," which began after the last locally transmitted patient was discharged on June 16.
"Throughout this period, the Ministry of Health maintained intensive surveillance nationwide, and no new Ebola cases have been detected," Baryomunsi said.
Earlier this month, Dr. Diana Atwine, Permanent Secretary at Uganda's Ministry of Health, said the outbreak had been successfully contained through rapid surveillance, prompt treatment, contact tracing, and close cross-border coordination.
Uganda recorded 20 confirmed Ebola cases during the outbreak. Of these, 18 patients recovered and were discharged, while two died.
Most of the infections were linked to travelers arriving from the DRC, with only a small number resulting from local transmission.
Despite the declaration, Baryomunsi urged the public to remain "vigilant" and continue following public health measures to prevent future outbreaks.
Also read: Michigan Cyclosporiasis Outbreak Nears 10,000 Cases: Is Your Lettuce Safe?
While Uganda celebrates its success, the Ebola crisis in the DRC continues to worsen. According to the Congolese Ministry of Health, the country has reported at least 3,262 cases and 1,437 deaths, bringing the outbreak close to the scale of the country's devastating 2018-2020 epidemic.
The World Health Organization (WHO) has described it as the fastest-spreading Ebola outbreak ever recorded, warning that the actual number of infections could be two to four times higher than officially reported.
United Nations humanitarian officials have described the outbreak as one of the world's most severe public health emergencies.
"The outbreak is spreading like wildfire," UN officials warned, citing armed conflict, mass displacement, and repeated attacks on healthcare facilities as major obstacles to controlling the virus.
The WHO has also warned that many newly reported infections cannot be linked to known transmission chains, suggesting the virus is spreading undetected within communities.
Contact tracing remains inadequate, while insecurity, misinformation, and community mistrust continue to undermine response efforts.
Health workers have also staged strikes in some areas over unpaid wages, further disrupting patient care and containment operations.
Attacks on health facilities, shortages of medical supplies, delayed laboratory testing, and public distrust are other factors delaying efforts to isolate patients, trace contacts, and break chains of transmission.
Amid the worsening outbreak, researchers have reached an important milestone in Ebola vaccine development.
The first volunteer has received an experimental vaccine targeting the Bundibugyo strain of Ebola, marking the world's first Phase I clinical trial for this virus, according to the University of Oxford.
The vaccine, ChAdOx1 BDBV, developed in collaboration with Serum Institute of India (SII), is designed specifically to protect against the Bundibugyo strain of Ebola.
It uses the same viral vector platform that powered the Oxford-AstraZeneca COVID-19 vaccine.
The vaccine uses a genetically modified chimpanzee adenovirus (ChAdOx1)—a harmless virus that normally causes the common cold in chimpanzees—as a delivery vehicle.
"We welcome the start of the phase 1 clinical trial of an investigational vaccine against Ebola Bundibugyo virus disease—an important step to assess the safety and immune responses generated by the vaccine," said WHO Director-General Tedros Adhanom Ghebreyesus on X.
© 2024 Bennett, Coleman & Company Limited